For the Inventor, By the Inventor

Enter assignee name

Brentwood, TN, United States of America

Currax Pharmaceuticals LLC

USPTO Granted Patents = 13

Trademarks = 14

Forward Citations = 0

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Philip Jochelson (9 out of 19 patents)

Neil Barton Kavey (8 out of 22 patents)

Roberta L Rogowski (7 out of 16 patents)

4. Susan E Dubé (7 out of 18 patents)

5. Michael Skinner (5 out of 9 patents)

6. Robert Mansbach (5 out of 9 patents)

7. Cara Baron Casseday (4 out of 8 patents)

8. Elizabeth Ludington (2 out of 4 patents)

9. Luigi Schioppi (2 out of 4 patents)

10. Brian Talmadge Dorsey (2 out of 4 patents)

11. John Carter (2 out of 7 patents)

12. Meredith Perry (2 out of 4 patents)

13. Bryan Knox (2 out of 4 patents)

14. Susan Ellen Dube (1 out of 2 patents)

15. Aaron Chesnut (1 out of 2 patents)

13 patents: Sort by Forward Citations

1. 12303604 - Pharmaceutical formulations comprising naltrexone and/or bupropion (2025-05-20),

2. 12083090 - Methods of using low-dose doxepin for the improvement of sleep (2024-09-10),

3. 11234954 - Low-dose doxepin for treatment of sleep disorders in elderly patients (2022-02-01),

4. 11110074 - Methods of improving the pharmacokinetics of doxepin (2021-09-07),

5. 11096920 - Low-dose doxepin formulations and methods of making and using the same (2021-08-24),

6. 11013712 - Methods of treating insomnia using a combination therapy of low-dose doxepin and zolpidem (2021-05-25),

7. 11007168 - Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders (2021-05-18),

8. 10758510 - Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders (2020-09-01),

9. 10653662 - Methods of using low-dose doxepin for the improvement of sleep (2020-05-19),

10. 10653660 - Methods of improving the pharmacokinetics of doxepin (2020-05-19),

11. 10548871 - Low-dose doxepin formulations and methods of making and using the same (2020-02-04),

12. 10507193 - Ultra low dose doxepin and methods of using the same to treat sleep disorders (2019-12-17),

13. 10493053 - Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders (2019-12-03),

Currax Pharmaceuticals LLC is a biopharmaceutical company based in Brentwood, Tennessee, focused on developing innovative therapies for patients with unmet medical needs. The company specializes in the formulation and commercialization of prescription medications, particularly in the areas of pain management and central nervous system disorders. Currax is committed to advancing healthcare solutions through its research initiatives and partnerships, aiming to improve patient outcomes and enhance quality of life.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#7 in Brentwood, TN

#250 in Tennessee

#23,815 in US

#44,988 in the World

Brentwood, TN, United States of America

Currax Pharmaceuticals LLC

Forward Citations = 0

16 inventors:

Philip Jochelson (9 out of 19 patents)

Neil Barton Kavey (8 out of 22 patents)

Roberta L Rogowski (7 out of 16 patents)

4. Susan E Dubé (7 out of 18 patents)

5. Michael Skinner (5 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…